Clinical Trials at Karrinyup Dermatology

We are currently recruiting participants for a clinical trial conducted in conjunction with pharmaceutical and research companies to advance dermatological care.

Are you a male experiencing pattern hair loss?

You may be eligible to join a clinical research study evaluating an investigational treatment designed to target a hormone pathway involved in hair follicle activity.

Androgenic alopecia, commonly known as male or female pattern hair loss, is a progressive condition that can cause thinning hair and changes in hair density over time.

Researchers are studying whether this investigational treatment may help support healthier hair growth cycles by targeting a biological pathway linked to hair follicle regulation.

Eligibility Criteria

You may qualify if you:

Are a male aged 18 to 65 years old
Have Androgenic Alopecia (moderate hair loss and thinning e.g., receding hairline, thinning at the crown)
Are not currently receiving treatment for hair loss
Are generally healthy and not taking chronic prescription medication

Other criteria apply. A member of our team will check if this study is a good fit for you.

Androgenic alopecia, commonly known as male or female pattern hair loss, is the most common form of hair loss and affects millions of men and women worldwide.

It is a gradual condition that alters the normal hair growth cycle, leading to progressive thinning of the hair on the scalp. In men, this often appears as a receding hairline or thinning at the crown.

Although it does not impact physical health, it can significantly affect confidence, self-image, and emotional wellbeing, making it a deeply personal and often distressing condition.

Current treatments for Androgenic alopecia include topical solutions and oral medications designed to slow hair thinning or stimulate regrowth. While these therapies can be effective for some individuals, results vary, and ongoing use is usually required to maintain benefits.

This study is exploring a new approach that targets a biological pathway involved in hair follicle regulation and scalp health. The research aims to deepen understanding of how this investigational therapy affects hair growth and overall follicle activity, and how it may contribute to the development of improved treatments in the future.

This is an early-phase clinical research study. Participants are not expected to receive a direct medical benefit. However, the knowledge gained may help researchers advance future therapies and improve care options for people living with Androgenic alopecia worldwide.